Vaxil’s ImMucin appears to have overcome a major drawback

New Post Public Reply Private Reply Replies (0) Message Board
Pussim
1,457
Vaxil’s ImMucin appears to have overcome a major drawback of using a vaccine to target a specific protein, namely that in many instances the vaccine has to be customized to the patient’s human leukocyte antigens (HLA), a system of genes unique to a person, which means a “silver bullet” solution for all is not possible.

“In the past, it was very difficult to induce immunity against tumor cells, with a very specific protein; we had to make a specific protein per type of HLA,” explained Vaxil’s Professor Michael Shapira.

ImMucin has been granted orphan drug status by both the US Food And Drug Administration and the European Medicine Agency, a status designed to encourage pharmaceutical companies to develop cures or treatments for rare diseases.

Vaxil founder Dr Lior Carmon said the recognition from the regulators served to both validate and enhance the company’s science.

ImMucin is a treatment that educates a cancer patient’s immune system to attack cancer cells via a specified domain, termed a signal peptide, of the MUC1 cancer antigen – an antigen being any substance that causes your immune system to produce antibodies. The MUC1 protein is often over-abundant in a diverse range of carcinomas – types of cancer that develop in the cells (epithelial cells) that line the surface of the body – and evidence of MUC1 is often an indication of several types of cancer, such as breast, lung, prostate and colon.

Patients in Vaxil’s trial were treated solely with the Immucin vaccine, as opposed to other cancer treatments such as chemotherapy or radiation, and all patients responded to the treatment, Professor Shapira told MCTV.

The professor confessed to being “astonished” that all patients developed specific immunity. Dr Carmon, meanwhile, drove home the significance of the test results, noting: “Importantly, in selected patients, a significant reduction in the percentage of plasma cells post [treatment] versus pre-treatment with ImMucin was observed.”
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anduin Opens Its Investor Portal Beyond Early Users

Updated Category News Views 68

Private-market paperwork has long been a swamp of portals, PDFs, email chains, and somebody chasing down a wire change at the worst possible moment. Anduin is taking a swing at that mess by opening its Investor Portal to all customers after building it with leading asset managers and operating it with their investors. The pitch is sensible: give limited partners one...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 23

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Duetti, CesiumAstro, and a Busy NYSE Capital Morning

Updated Category News Views 73

Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....

Continue Reading
Cleveland Picks Golden Key for Citywide Leadership Training

Updated Category News Views 215

A Citywide Bet on Better Management Municipal management rarely grabs headlines until something breaks, which is precisely why Cleveland's decision to bring in Golden Key Group deserves a closer look. Announced November 20, 2026, the arrangement calls for GKG to design and deliver a citywide management training program through Cleveland's Department of Personnel and Human...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 28

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading
Perigon Builds Its Investment Bench for the Next Leg

Updated Category News Views 91

Perigon is rearranging the engine room before the next growth spurt gets noisy. The firm has named Christopher Broderick Director of Investments and Research, added two trading associates, and put another brick behind the broader operating structure Rafia Hasan has been assembling since taking on the chief operating officer role in August. That may sound like ordinary...

Continue Reading
Fervo IPO Lawsuit Puts 71% Share Collapse in Focus

Updated Category News Views 13

Fervo’s $27 debut has turned into the sort of wreckage IPO buyers dread: shares were alleged to have closed as low as $7.79 when the complaint was filed. That is more than a 71% fall from the May 13, 2026 offering price, and it puts a hard, ugly number beside the new securities class action against the geothermal power developer. More Than a Bad Quarter Is Being Alleged...

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 0

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
KidneyVoter Push Turns Patient Frustration Into Clout

Updated Category News Views 75

A ballot registration drive rarely tells the whole story, but it can reveal where the pressure is building. The American Association of Kidney Patients says its 2026 nonpartisan KidneyVoter™ effort, “50 States in 50 Days,” reached constituencies in every state after launching September 14. That does not produce a clean vote total or prove legislators will suddenly...

Continue Reading
Page Library Grant Makes a Practical Case for Access

Updated Category News Views 56

A library card is not much use if a family cannot reach the help behind it. That plain reality sits at the center of AZ Blue Health Choice’s $10,000 contribution to the Page Public Library Family Resource Center, announced November 20, 2026. This is a modest dollar figure in the grand scheme of health care, but it is aimed at the kind of everyday gaps that can become...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Eli Lilly's Short Interest Trends and Market Sentiment

Updated Category News Views 217

Eli Lilly's Short Interest Overview The short interest for Eli Lilly has noticeably risen by 14.71% since the last report. Currently, there are about 6.27 million shares that have been sold short, which accounts for roughly 0.78% of all regularly traded shares. At the present trading volume, analysts estimate that it would take around 2.41 days for traders to close out...

Continue Reading
Bluevua Expands Reach with Major Online Retailers

Updated Category News Views 21

An Ecommerce Splash for Water Purification Here we are, diving headfirst into yet another tale of market expansion. Bluevua, a name that's been making waves with its reverse osmosis (RO) systems, just secured a roster spot on some of the biggest online retail giants: Target.com, Lowes.com, and Walmart.com. Sure, not every trader is into the nitty-gritty of water...

Continue Reading
Building Products M&A Trends Indicate a Bright Future Ahead

Updated Category News Views 108

Building Products M&A Trends: A Bright Future Ahead The building products mergers and acquisitions (M&A) sector is on the verge of significant growth as we approach 2026. This promising trajectory is rooted in the optimism surrounding the long-term prospects of the U.S. housing market. An analysis provided by experts in the industry illustrates the resilient nature of...

Continue Reading
Recursion to Share Pivotal REC-4881 Data at DDW 2025 Event

Updated Category News Views 499

Recursion to Share Pivotal REC-4881 Data at DDW 2025 Event Recursion, a pioneering clinical stage TechBio company, is set to unveil groundbreaking preliminary data regarding REC-4881 during the prominent Digestive Disease Week (DDW) event in 2025. This gathering is critical as it showcases advancements in gastrointestinal medicine and research. The data will be...

Continue Reading
Reviving the Legend: Remus Bourbon's Babe Ruth Reserve 2025

Updated Category News Views 258

Reviving a Baseball Legend with Remus Bourbon Remus Bourbon is excited to introduce its latest release, the 2025 Babe Ruth Reserve. This special edition pays homage to Babe Ruth, an icon in the world of baseball known as the Sultan of Swat. With only 8,399 bottles available, this limited production truly captures the spirit of both the game and the whiskey-making...

Continue Reading